Industry News

Medical Device Industry News

MOWOOT earns FDA’s First-Ever ‘Breakthrough Device Designation’ for a Novel Non-Drug and Non-Invasive Therapy of Neurogenic Bowel Disorder

December 17th, 2021|Medical Device News Magazine|

"The Breakthrough Device Designation is a significant milestone for our company and validates our belief that our solution offers significant advantages over existing approved or cleared alternatives, per FDA requirements." said Dr. Markus Wilhelms, CEO

MOWOOT earns FDA’s First-Ever ‘Breakthrough Device Designation’ for a Novel Non-Drug and Non-Invasive Therapy of Neurogenic Bowel Disorder

December 17th, 2021|Medical Device News Magazine|

"The Breakthrough Device Designation is a significant milestone for our company and validates our belief that our solution offers significant advantages over existing approved or cleared alternatives, per FDA requirements." said Dr. Markus Wilhelms, CEO

Nanotransfection Device for Tissue Reprogramming In Situ

December 16th, 2021|Medgadget|

Genetic modification offers huge potential in treating a wide variety of conditions, but the devil is in the details. Previously explored methods to deliver genes into cells, such as using viral vectors, have been connected

Nanotransfection Device for Tissue Reprogramming In Situ

December 16th, 2021|Medgadget|

Genetic modification offers huge potential in treating a wide variety of conditions, but the devil is in the details. Previously explored methods to deliver genes into cells, such as using viral vectors, have been connected